We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

ZEUS SCIENTIFIC

ZEUS Scientific provides high-performing, easy-to-use clinical diagnostic solutions. The company’s products are desig... read more Featured Products: More products

Download Mobile App




State-of-the-Art IFA Automation Solution Improves Laboratory Workflow

By LabMedica International staff writers
Posted on 19 May 2023
Print article
Image: The ZEUS dIFine digital immunofluorescence system (Photo courtesy of ZEUS Scientific)
Image: The ZEUS dIFine digital immunofluorescence system (Photo courtesy of ZEUS Scientific)

Laboratories are focused on improving efficiency, accuracy, and most importantly, productivity. Now, a complete system for indirect fluorescent antibody (IFA) slide processing and digital immunofluorescence imaging allows labs to increase their productivity while leaving them free to focus on more important tasks.

ZEUS Scientific’s (Branchburg, NJ, USA) new dIFine 30 System combines its next-generation digital IFA imaging and interpretation system with its user-friendly and efficient benchtop instrument for IFA slide processing, including cover slipping. The SP30, a fully automated IFA slide processor for the dIFine digital immunofluorescence system, is an easy-to-use and efficient walk-away benchtop instrument. Capable of processing up to 240 samples on 30 IFA slides, including cover slipping, the SP30 IFA slide processor for dIFine is engineered to enhance laboratory workflow and guarantee superior results.

ZEUS dIFine represents the future of IFA imaging and pattern recognition. This FDA-approved, automated digital scanner equipped with intelligent software is designed to acquire, analyze, display, and store digital images of ZEUS HEp-2 IFA slides. ZEUS dIFine rapidly generates positive/negative results and has received FDA clearance to suggest eight common ANA HEp-2 patterns (homogenous, speckled, centromere, nucleolar, nuclear dots, nuclear membrane, cytoplasmic, ribosomal, and mitochondrial). Additionally, dIFine can quickly locate and identify mitotic cells to aid in pattern identification. The ability to rapidly view and validate all negative samples with a single mouse click saves the user precious time. The built-in pattern atlas serves as a reference and a useful training tool, allowing for side-by-side comparison of images with ZEUS proprietary images aligned with ICAP nomenclature.

Related Links:
ZEUS Scientific 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.